Infectious complications of acute pancreatitis

Acta Clinica Belgica

Volumn 59, Issue 2, 2004, Pages 90-96

  De Waele, J ^a   Vogelaers, D ^a   Decruyenaere, J ^a   De Vos, M ^a   Colardyn, F ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Abdominal infections; Acute pancreatitis; Pancreatic abscess

Indexed keywords

AMPHOTERICIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFOTAXIME; CEFUROXIME; FLUCONAZOLE; IMIPENEM; INSULIN; PEFLOXACIN; POLYMYXIN B; TOBRAMYCIN;

ACUTE PANCREATITIS; ADVERSE DRUG REACTION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPIRATION BIOPSY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOGRAPHY; ENTERIC FEEDING; HUMAN; INCIDENCE; INFECTION; LACTOBACILLUS PLANTARUM; LAVAGE; MORBIDITY; MORTALITY; MYCOSIS; NONHUMAN; PANCREAS ABSCESS; PANCREAS NECROSIS; PANCREAS PSEUDOCYST; POSTOPERATIVE INFECTION; RISK FACTOR; SURGICAL DRAINAGE; SURVIVAL; VEIN THROMBOSIS;

EID: 2642529488     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2004.013     Document Type: Article

References (67)

1. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994;330:1198-210.
2. Bradley EL, 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993;128:586-90.
3. Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989;76:177-81.
4. Frossard JL, Hadengue A, Pastor CM. New serum markers for the detection of severe acute pancreatitis in humans. Am J Respir Crit Care Med 2001;164:162-70.
5. Riche FC, Cholley BP, Laisne MJ, et al. Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis. Surgery 2003;133:257-62.
6. Khan AA, Parekh D, Cho Y, et al. Improved Prediction of Outcome in Patients With Severe Acute Pancreatitis by the APACHE II Score at 48 Hours After Hospital Admission Compared With the APACHE II Score at Admission. Arch Surg 2002;137:1136-40.
7. Eachempati SR, Hydo LJ, Barie PS. Severity scoring for prognostication in patients with severe acute pancreatitis: comparative analysis of the Ranson score and the APACHE III score. Arch Surg 2002;137:730-6.
8. Cicalese L, Sahai A, Sileri P, et al. Acute pancreatitis and bacterial translocation. Dig Dis Sci 2001;46:1127-32.
9. Pupelis G, Austrums E, Snippe K, Berzins M. Clinical significance of increased intraabdominal pressure in severe acute pancreatitis. Acta Chir Belg 2002;102:71-4.
10. Schein M, Wittmann DH, Aprahamian CC, Condon RE. The abdominal compartment syndrome: the physiological and clinical consequences of elevated intra-abdominal pressure. J Am Coll Surg 1995;180:745-53.
11. Diebel LN, Dulchavsky SA, Brown WJ. Splanchnic ischemia and bacterial translocation in the abdominal compartment syndrome. J Trauma 1997;43:852-5.
12. Diebel LN, Dulchavsky SA, Wilson RF. Effect of increased intra-abdominal pressure on mesenteric arterial and intestinal mucosal blood flow. J Trauma 1992;33:45-8; discussion 48-9.
13. Gloor B, Muller CA, Worni M, Martignoni ME, Uhl W, Buchler MW. Late mortality in patients with severe acute pancreatitis. Br J Surg 2001;88:975-9.
14. Sainio V, Kemppainen E, Puolakkainen P, et al. Early antibiotic treatment in acute necrotising pancreatitis. Lancet 1995;346:663-7.
15. Pederzoli P, Bassi C, Vesentini S, Campedelli A. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 1993;176:480-3.
16. Bassi C, Falconi M, Talamini G, et al. Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis. Gastroenterology 1998;115:1513-7.
17. Toouli J, Brooke-Smith M, Bassi C, et al. Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol 2002;17 Suppl:S15-39.
18. Uhl W, Warshaw A, Imrie C, et al. IAP Guidelines for the Surgical Management of Acute Pancreatitis. Pancreatology 2002;2:565-73.
19. Baron TH, Morgan DE. Acute necrotizing pancreatitis. N Engl J Med 1999;340:1412-7.
20. Dervenis C, Johnson CD, Bassi C, et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol 1999;25:195-210.
21. Sharma VK, Howden CW. Prophylactic antibiotic administration reduces sepsis and mortality in acute necrotizing pancreatitis: a meta-analysis. Pancreas 2001;22:28-31.
22. Maravi-Poma E, Gener J, Alvarez-Lerma F, Olaechea P, Blanco A, Dominguez-Munoz JE. Early antibiotic treatment (prophylaxis) of septic complications in severe acute necrotizing pancreatitis: a prospective, randomized, multicenter study comparing two regimens with imipenem-cilastatin. Intensive Care Med 2003;29:1974-80.
23. Gloor B, Muller CA, Worni M, et al. Pancreatic infection in severe pancreatitis: the role of fungus and multiresistant organisms. Arch Surg 2001;136:592-6.
24. Luiten EJ, Hop WC, Lange JF, Bruining HA. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 1995;222:57-65.
25. Nathens AB, Marshall JC. Selective decontamination of the digestive tract in surgical patients: a systematic review of the evidence. Arch Surg 1999;134:170-6.
26. Grewe M, Tsiotos GG, Luque de-Leon E, Sarr MG. Fungal infection in acute necrotizing pancreatitis. J Am Coll Surg 1999;188:408-14.
27. Gotzinger P, Wamser P, Barlan M, Sautner T, Jakesz R, Fugger R. Candida infection of local necrosis in severe acute pancreatitis is associated with increased mortality. Shock 2000;14:320-3; discussion 323-4.
28. Hoerauf A, Hammer S, Muller-Myhsok B, Rupprecht H. Intra-abdominal Candida infection during acute necrotizing pancreatitis has a high prevalence and is associated with increased mortality. Crit Care Med 1998;26:2010-5.
29. De Waele JJ, Vogelaers D, Blot S, Colardyn F. Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy. Clin Infect Dis 2003;37:208-13.
30. McKinnon PS, Goff DA, Kern JW, et al. Temporal assessment of Candida risk factors in the surgical intensive care unit. Arch Surg 2001;136:1401-8.
31. Moore FA, Feliciano DV, Andrassy RJ, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg 1992;216:172-83.
32. Erstad BL. Enteral nutrition support in acute pancreatitis. Ann Pharmacother 2000;34:514-21.
33. Kalfarentzos F, Kehagias J, Mead N, Kokkinis K, Gogos CA. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg 1997;84:1665-9.
34. Olah A, Pardavi G, Belagyi T, Nagy A, Issekutz A, Mohamed GE. Early nasojejunal feeding in acute pancreatitis is associated with a lower complication rate. Nutrition 2002;18:259-62.
35. Al-Omran M, Groof A, Wilke D. Enteral versus parenteral nutrition for acute pancreatitis. In: The Cochrane Library: Oxford: Update Software; 2002.
36. Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 2002;89:1103-7.
37. Dubner H, Steinberg W, Hill M, Bassi C, Chardavoyne R, Bank S. Infected pancreatic necrosis and peripancreatic fluid collections: serendipitous response to antibiotics and medical therapy in three patients. Pancreas 1996;12:298-302.
38. Carter CR, McKay CJ, Imrie CW. Percutaneous necrosectomy and sinus tract endoscopy in the management of infected pancreatic necrosis: an initial experience. Ann Surg 2000;232:175-80.
39. De Waele JJ, Hesse UJ, Pattyn P, Decruyenaere J, de Hemptinne B. Postoperative lavage and on demand surgical intervention in the treatment of acute necrotizing pancreatitis. Acta Chir Belg 2000;100:16-20.
40. Bosscha K, Hulstaert PF, Hennipman A, et al. Fulminant acute pancreatitis and infected necrosis: results of open management of the abdomen and "planned" reoperations. J Am Coll Surg 1998;187: 255-62.
41. Beger HG, Buchler M, Bittner R, Block S, Nevalainen T, Roscher R. Necrosectomy and postoperative local lavage in necrotizing pancreatitis. Br J Surg 1988;75:207-12.
42. Farkas G, Marton J, Mandi Y, Szederkenyi E. Surgical strategy and management of infected pancreatic necrosis. Br J Surg 1996;83:930-3.
43. Gotzinger P, Sautner T, Kriwanek S, et al. Surgical treatment for severe acute pancreatitis: extent and surgical control of necrosis determine outcome. World J Surg 2002;26:474-8.
44. D'Egidio A, Schein M. Surgical strategies in the treatment of pancreatic necrosis and infection. Br J Surg 1991;78:133-7.
45. Beger HG, Isenmann R. Surgical management of necrotizing pancreatitis. Surg Clin North Am 1999;79:783-800, ix.
46. Castellanos G, Pinero A, Serrano A, Parrilla P. Infected pancreatic necrosis: translumbar approach and management with retroperitoneoscopy. Arch Surg 2002;137:1060-3.
47. Paye F, Frileux P, Lehman P, Ollivier JM, Vaillant JC, Parc R. Reoperation for severe pancreatitis: a 10-year experience in a tertiary care center. Arch Surg 1999;134:316-20.
48. Doepel M, Eriksson J, Halme L, Kumpulainen T, Hockerstedt K. Good long-term results in patients surviving severe acute pancreatitis. Br J Surg 1993;80:1583-6.
49. Holden JL, Berne TV, Rosoff L, Sr. Pancreatic abscess following acute pancreatitis. Arch Surg 1976;111:858-61.
50. Bittner R, Block S, Buchler M, Beger HG. Pancreatic abscess and infected pancreatic necrosis. Different local septic complications in acute pancreatitis. Dig Dis Sci 1987;32:1082-7.
51. Becker JM, Pemberton JH, DiMagno EP, Ilstrup DM, McIlrath DC, Dozois RR. Prognostic factors in pancreatic abscess. Surgery 1984;96:455-61.
52. Warshaw AL, Jin GL. Improved survival in 45 patients with pancreatic abscess. Ann Surg 1985;202:408-17.
53. Gerkin TM, Eckhauser FE, Raper SE, Mulholland MW, Knol JA, Schork MA. Are traditional prognostic criteria useful in pancreatic abscess? Pancreas 1995;10:331-7.
54. Aranha GV, Prinz RA, Greenlee HB. Pancreatic abscess: an unresolved surgical problem. Am J Surg 1982;144:534-8.
55. Brook I, Frazier EH. Microbiological analysis of pancreatic abscess. Clin Infect Dis 1996;22:384-5.
56. Mithofer K, Mueller PR, Warshaw AL. Interventional and surgical treatment of pancreatic abscess. World J Surg 1997;21:162-8.
57. Baril NB, Ralls PW, Wren SM, et al. Does an infected peripancreatic fluid collection or abscess mandate operation? Ann Surg 2000;231:361-7.
58. Park JJ, Kim SS, Koo YS, et al. Definitive treatment of pancreatic abscess by endoscopic transmural drainage. Gastrointest Endosc 2002;55:256-62.
59. Venu RP, Brown RD, Marrero JA, Pastika BJ, Frakes JT. Endoscopic transpapillary drainage of pancreatic abscess: technique and results. Gastrointest Endosc 2000;51:391-5.
60. Torres WE, Evert MB, Baumgartner BR, Bernardino ME. Percutaneous aspiration and drainage of pancreatic pseudocysts. Am J Roentgenol 1986;147:1007-9.
61. O'Malley VP, Cannon JP, Postier RG. Pancreatic pseudocysts: cause, therapy, and results. Am J Surg 1985;150:680-2.
62. Boerma D, van Gulik TM, Obertop H, Gouma DJ. Internal drainage of infected pancreatic pseudocysts: safe or sorry? Dig Surg 1999;16:501-5.
63. Mullins RJ, Malangoni MA, Bergamini TM, Casey JM, Richardson JD. Controversies in the management of pancreatic pseudocysts. Am J Surg 1988;155:165-72.
64. Spivak H, Galloway JR, Amerson JR, et al. Management of pancreatic pseudocysts. J Am Coll Surg 1998;186:507-11.
65. Heider R, Meyer AA, Galanko JA, Behms KE. Percutaneous drainage of pancreatic pseudocysts is associated with a higher failure rate than surgical treatment in unselected patients. Ann Surg 1999;229:781-7; discussion 787-9.
66. Fedorak IJ, Ko TC, Djuricin G, McMahon M, Thompson K, Prinz RA. Secondary pancreatic infections: are they distinct clinical entities? Surgery 1992;112:824-30.
67. De Waele JJ, Blot S, Hoste E, Vandewoude K, Colardyn F. Pancreatic surinfection after surgery for acute necrotozing pancreatitis. In: Program and abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego. Washington DC: Americal Society for Microbiology; 2002. p. 337.